Companies in Melbourne

BHP is one of the world's largest diversified mining companies, tracing its roots to the Broken Hill Proprietary Company founded in Australia in 1885 and the Billiton mining company founded in the Netherlands in 1860; the two merged in 2001. Headquartered in Melbourne, Australia, BHP employs about 80,000 people and generates annual revenue of roughly US$55 billion from iron ore, copper, coal, nickel, and potash. BHP's flagship operations include the Pilbara iron ore province in Western Australia, the Escondida copper mine in Chile — the world's largest copper mine — and the Olympic Dam multi-commodity operation in South Australia. The company is repositioning its portfolio around copper and potash to serve the energy transition, having divested most of its petroleum and thermal coal assets. For industrial buyers, BHP is a benchmark supplier of iron ore and copper concentrate, with transparent quality specifications, standardized pricing mechanisms, and some of the longest-running supply contracts in the mining industry.

Rio Tinto is one of the world's largest metals and mining corporations, founded in 1873 when a British consortium bought the Rio Tinto copper mines in southern Spain. Today the group is dual-listed in London and Sydney, employs around 53,000 people, and produces iron ore, aluminium, copper, lithium, and a range of industrial minerals across 35 countries. The company's iron ore business, centered on the Pilbara region of Western Australia, ships more than 300 million tonnes per year to steelmakers in China, Japan, and Korea. Its aluminium arm, built around the 2007 acquisition of Alcan, operates smelters powered largely by hydroelectricity, giving it one of the lowest-carbon aluminium footprints in the industry. Rio Tinto is also developing the Oyu Tolgoi copper mine in Mongolia, one of the largest undeveloped copper deposits in the world. For buyers of metals and minerals, Rio Tinto offers consistent product quality, large-scale logistics, and growing volumes of 'green' aluminium and copper that help downstream manufacturers meet carbon-reduction targets.

CSL is a global biotechnology company headquartered in Melbourne, Australia, and one of the world's largest producers of plasma-derived and recombinant therapies. Founded in 1916 as the Commonwealth Serum Laboratories, CSL has grown into a USD 13 billion revenue company with operations in more than 35 countries and manufacturing facilities across Australia, the US, Europe and Asia. The company's CSL Behring division is a world leader in plasma therapies for immunology, haematology, critical care and infectious disease, while CSL Seqirus is a top global influenza vaccine manufacturer, and CSL Vifor focuses on iron deficiency and nephrology. CSL operates one of the world's largest plasma collection networks, with over 300 collection centres. For B2B buyers, CSL supplies plasma-derived therapies, vaccines and specialty pharmaceuticals to hospitals, distributors and government health programs worldwide. Its manufacturing excellence, regulatory track record and R&D pipeline make it a critical partner in the global biopharmaceutical supply chain.